Research Article
How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients?
Table 1
Characteristics of the study group (sociodemographic and clinical variables).
| Characteristics | Mean (SD) | Median (Q1 – Q3) |
| Age [years] | 72.09 (7.98) | 69 (65 – 78) |
| Systolic blood pressure [mmHg] | 141.57 (16.95) | 140 (130 – 150) |
| Diastolic blood pressure [mmHg] | 84.89 (12.86) | 90 (80 – 90) |
| Duration of disease [years] | 14.31 (9.19) | 14 (7 – 17.25) |
| Characteristics | N | |
| Sex | Women | 91 | 56.88% | Men | 69 | 43.12% |
| Marital status | Married / Living together | 84 | 52.50% | Unmarried | 7 | 4.38% | Separated / Divorced | 5 | 3.12% | Widowed | 64 | 40.00% |
| Education | None or basic | 55 | 34.38% | Secondary | 60 | 37.50% | Higher | 45 | 28.12% |
| Occupational activity | Employed | 37 | 23.12% | Retired | 106 | 66.25% | Annuitant | 17 | 10.62% | Unemployed | 0 | 0.00% |
| BMI | Underweight (17 – 18.5) | 1 | 0.62% | Normal weight (18.5 – 25) | 42 | 26.25% | Overweight (25 – 30) | 71 | 44.38% | Obese class I (30 – 35) | 31 | 19.38% | Obese class II (35 – 40) | 10 | 6.25% | Obese class III ( > 40) | 5 | 3.12% |
| JNC-7 classification of HT | Prehypertension | 39 | 24.38% | Stage I HT | 90 | 56.25% | Stage II HT | 31 | 19.38% |
| Co-morbidities | Diabetes | 86 | 53.75% | Hypercholesterolemia | 49 | 30.63% | Coronary disease | 47 | 29.38% | Renal failure | 20 | 12.50% | Rheumatic diseases | 27 | 16.88% |
| Medications administration | Alpha-adrenolytic | 6 | 3.75% | Beta-adrenolytic | 45 | 28.12% | Calcium channel blocker (CCB) | 46 | 28.75% | Angiotensin receptor blocker (ARB) | 14 | 8.75% | Beta-blocker (BB) | 4 | 2.50% | Loop diuretic (LD) | 3 | 1.88% | Thiazide diuretic (TD) | 62 | 38.75% | Angiotensin-converting-enzyme inhibitors (ACEI) | 105 | 65.62% |
| Therapy | Monotherapy | 72 | 45.00% | Polytherapy | 88 | 55.00% |
|
|
Multiple choice questions, percentages don’t add up to 100%. ACEI: angiotensin-converting-enzyme inhibitors; ARB: angiotensin receptor blocker; BB: beta-blocker; BMI: body mass index; CCB: calcium channel blocker; HT: hypertension; JNC: Joint National Committee; LD: loop diuretic; N: number of patients; Q1-Q3: quartile -; SD: standard deviation; TD: thiazide diuretic. |